In this study, we showed that BRCA1 expression was upregulated by oxaliplatin exposure alone, whereas vorinostat downregulated BRCA1 expression in the presence or absence of oxaliplatin in HCC cells (Fig. 6). Here, BRCA1 is linked to hepatocellular carcinoma.